Earlier this week, the federal Food and Drug Administration (FDA) approved the use of the drug aducanumab to treat Alzheimer’s disease—making it the first new drug in nearly 20-years to
Singapore will begin slowly easing a month-long partial lockdown from next week after the curbs succeeded in stemming a coronavirus outbreak, authorities said Thursday.
The World Health Organization (WHO) warned Thursday that vaccination rates in Europe were still far off what was needed to stop a virus resurgence and called on countries to maintain
New research published this week by the Armed Forces charity SSAFA conducted by the University of Bath highlights the positive impact of wellbeing interventions for veterans.
What options do cancer survivors have during a pandemic when there are limited in-person training options and reduced access to exercise facilities? With National Cancer Survivors Day on June 6,
The life-saving diabetic medication insulin, developed at the University of Toronto 100 years ago, was the first biologic therapy—a protein to treat disease. A century later, a new biologic therapy
The number of GPs who say they were likely to quit direct patient care within five years was 37%, even before the coronavirus pandemic, according to a new survey carried
By studying the biomechanics of cancer in the breast and bladder, the Mechano-Control and Edit projects are developing new ways of cancer identification and treatment that could open up new
Although it was first reported in 1880, there has been little research conducted on prurigo nodularis (PN), an inflammatory chronic skin disorder characterized by firm, intensely itchy nodules that appear
Alzheimer’s disease is one of medicine’s most elusive thieves, a disease that slowly and irreversibly robs a person’s ability to think, reason, remember and maintain normal body functioning. The underlying